Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia

Allogeneic stem cell transplantation remains the standard treatment for resistant advanced chronic myeloid leukemia and Philadelphia chromosome–positive acute lymphoblastic leukemia. Relapse is the major cause of treatment failure in both diseases. Post-allo-SCT administration of TKIs could potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Varda-Bloom, Nira, Danylesko, Ivetta, Shouval, Roni, Eldror, Shiran, Lev, Atar, Davidson, Jacqueline, Rosenthal, Esther, Volchek, Yulia, Shem-Tov, Noga, Yerushalmi, Ronit, Shimoni, Avichai, Somech, Raz, Nagler, Arnon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352130/
https://www.ncbi.nlm.nih.gov/pubmed/27880933
http://dx.doi.org/10.18632/oncotarget.13439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352130/
https://www.ncbi.nlm.nih.gov/pubmed/27880933
http://dx.doi.org/10.18632/oncotarget.13439

Ejemplares similares